Evonik's 24-Euro Question: What Would Actually Bring BASF Back to the Table
Published on 11/21/2026 at 13:21 | Editorial boerse-global.deEvonik's shares are trading well below the price BASF was willing to pay, and that gap tells the story of a takeover that stalled rather than one that collapsed. The specialty chemicals maker closed at €18.18 on Friday, down from the €24 per share offered in BASF's final all-cash proposal — a bid that valued the company at roughly €11.18 billion.
BASF walked away this week after Evonik's board rejected two non-binding cash offers. For Bernstein analyst James Hooper, a resumption of talks is conceivable — but only on Evonik's initiative. The company would have to approach BASF and demonstrate that it is worth more than €24 a share. Hooper's scenario is a description of the hurdles, not a forecast of a fresh bid.
Two Conditions, Not One
Price alone would not reopen negotiations. Evonik would first need to signal willingness to engage, then convince BASF that its standalone prospects justify a richer valuation. BASF, for its part, concluded that a higher price was not warranted given the opportunities and risks of Evonik's independent path. The Ludwigshafen group had weighed a modest increase but never tabled a further offer.
Access to the books was the other sticking point. According to BASF, Evonik's management was unwilling to open its accounts for deeper due diligence. Chief executive Markus Kamieth nonetheless maintained that a combination could have created a stronger chemicals group.
Should investors sell immediately? Or is it worth buying Evonik?
Politics and the Foundation's Regret
The Frankfurter Allgemeine Zeitung reported that political resistance in North Rhine-Westphalia played a decisive role in BASF's retreat. Minister President Hendrik Wüst pointed to 11,000 Evonik jobs in the state — and Wüst also sits on the RAG-Stiftung's board of trustees. BASF had already offered protections for German sites, research and employment through 2032 in October.
RAG-Stiftung, Evonik's largest shareholder with 43%, voiced regret on Friday that deeper talks between the two boards never took place. That regret should not be read as endorsement of a sale on the terms offered. The foundation intends to cut its stake step by step to 25.1% and build up other capital investments to fund the long-term costs of hard-coal mining — which is why Evonik's dividend carries real weight for it.
The Standalone Yardstick
With BASF out of the picture, attention shifts to what Evonik can deliver on its own. Interim chief Claus Rettig has committed to continuing the company's standalone growth strategy, leaving investors to judge the potential of the specialty chemicals business without a merger. For RAG-Stiftung, the growth question comes bundled with another: what distributions Evonik can sustain on that course.
Evonik at a turning point? This analysis reveals what investors need to know now.
The spread between the last offer and the current share price is not a potential takeover gain. Until a new bid materializes, it is simply the market's verdict on the standalone story — and on how far Evonik would have to travel to prove Hooper's €24-plus case.
Ad
Evonik Stock: New Analysis - 21 November
Fresh Evonik information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
